Conversely, overexpression of S1PR1 or pharmacological administration of an S1PR1 agonist in the DG, promoted an unsusceptible phenotype, thereby averting the onset of memory impairment, and alleviated morphological abnormalities in DGCs. Here, S1PR1 is linked to memory impairment.